/Companies

晶蛋生物

1 known investors

Find your way into 晶蛋生物

Sign up to see every warm intro you have to 晶蛋生物

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the 晶蛋生物 team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Crystalo Bio provides structural biology and drug discovery services focused on membrane proteins such as GPCRs, ion channels, and transporters, using crystallography, cryo-EM, and NMR. It also offers end-to-end antibody development services (antigen preparation, humanization, nanobodies, bispecific nanobodies) and computational molecular modeling and simulation for pharmaceutical research.

Investors · 1

Frequently asked questions

What does 晶蛋生物 do?
Crystalo Bio provides structural biology and drug discovery services focused on membrane proteins such as GPCRs, ion channels, and transporters, using crystallography, cryo-EM, and NMR. It also offers end-to-end antibody development services (antigen preparation, humanization, nanobodies, bispecific nanobodies) and computational molecular modeling and simulation for pharmaceutical research.
Who are 晶蛋生物's investors?
晶蛋生物's investors include TriWise Capital.